US EditionGlass Pharms Signs Supply Agreement With CB1 Pharmacy Offering 3 New Affordable UK-Grown Strains - Business of Cannabis
Summary by Business of Cannabis
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Glass Pharms Signs Supply Agreement With CB1 Pharmacy Offering 3 New Affordable UK-Grown Strains - Business of Cannabis
Glass Pharms has today announced a new supply deal set to see a new line of affordable, entirely UK-produced products enter the market. Three new additions to the ‘EcoCann Access’ range, derived from Glass Pharms’ sustainably grown flower, will now be prescribed through CB1 Pharmacy and manufactured by Xeal Pharma. The products are designed to provide a consistent and budget-friendly option for UK patients, with prices set at under £6 per gram, …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
